Drug intelligence / Profile preview

IVL2005

Development stage: Preclinical
Lead developer: Inventage Lab
Modality: Peptides
Administration: Subcutaneous, Intramuscular

Overview

IVL2005 is a long-acting injectable peptide candidate being developed by Inventage Lab, in collaboration with Virbac, for veterinary applications. It functions as a gonadotropin-releasing hormone (GnRH) receptor modulator intended for chemical castration and the management of reversible infertility in animals. The formulation leverages Inventage Lab's proprietary microsphere-based drug delivery technology to ensure sustained release of the therapeutic peptide, providing a reversible and non-invasive alternative to surgical procedures. The program is currently in preclinical development.

Targets

GnRHR (Gonadotropin-releasing hormone receptor)

Beyond the preview

Go deeper on IVL2005.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVL2005.

Explore the full profile